VYNT
Income statement / Annual
Last year (2022), Vyant Bio, Inc.'s total revenue was $666,000.00,
a decrease of 41.99% from the previous year.
In 2022, Vyant Bio, Inc.'s net income was -$22.69 M.
See Vyant Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$666,000.00 |
$1.15 M |
$867,000.00 |
$7.31 M |
$27.47 M |
$29.12 M |
$27.05 M |
$18.04 M |
$10.20 M |
$6.61 M |
| Cost of Revenue |
$1.01 M
|
$1.85 M
|
$1.10 M
|
$3.70 M
|
$18.72 M
|
$18.07 M
|
$17.10 M
|
$14.10 M
|
$8.45 M
|
$4.92 M
|
| Gross Profit |
-$342,000.00
|
-$699,000.00
|
-$234,000.00
|
$3.60 M
|
$8.75 M
|
$11.05 M
|
$9.95 M
|
$3.94 M
|
$1.75 M
|
$1.69 M
|
| Gross Profit Ratio |
-0.51
|
-0.61
|
-0.27
|
0.49
|
0.32
|
0.38
|
0.37
|
0.22
|
0.17
|
0.25
|
| Research and Development Expenses |
$6.77 M
|
$4.27 M
|
$3.23 M
|
$0.00
|
$2.49 M
|
$4.79 M
|
$5.97 M
|
$5.48 M
|
$4.62 M
|
$2.19 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$6.60 M
|
$5.17 M
|
$19.18 M
|
$19.89 M
|
$16.03 M
|
$14.57 M
|
$12.37 M
|
$6.12 M
|
| Selling & Marketing Expenses |
$8.80 M
|
$8.42 M
|
$2.72 M
|
$1.15 M
|
$5.27 M
|
$4.99 M
|
$4.67 M
|
$5.27 M
|
$3.96 M
|
$1.84 M
|
| Selling, General & Administrative Expenses |
$8.80 M
|
$8.42 M
|
$2.72 M
|
$6.32 M
|
$24.45 M
|
$24.88 M
|
$20.70 M
|
$19.84 M
|
$16.33 M
|
$7.96 M
|
| Other Expenses |
$0.00
|
$57,000.00
|
$11,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$15.57 M
|
$12.70 M
|
$5.95 M
|
$6.32 M
|
$26.94 M
|
$29.67 M
|
$26.67 M
|
$25.32 M
|
$20.95 M
|
$10.15 M
|
| Cost And Expenses |
$16.58 M
|
$14.54 M
|
$7.05 M
|
$10.02 M
|
$45.66 M
|
$47.74 M
|
$43.77 M
|
$39.42 M
|
$29.41 M
|
$15.07 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$108,000.00
|
$21,000.00
|
$63,000.00
|
$23,000.00
|
$49,000.00
|
$73.80 M
|
$29.69 M
|
| Interest Expense |
$93,000.00
|
$0.00
|
$535,000.00
|
$1.44 M
|
$2.12 M
|
$2.13 M
|
$454,000.00
|
$344,000.00
|
$472,820.00
|
$2.39 M
|
| Depreciation & Amortization |
$843,000.00
|
$8.23 M
|
$2.56 M
|
$757,000.00
|
$2.11 M
|
$2.17 M
|
$2.38 M
|
$1.66 M
|
$838,596.00
|
$326,476.00
|
| EBITDA |
-$15.07 M |
-$15.71 M |
-$5.06 M |
-$5.03 M |
-$16.14 M |
-$18.62 M |
-$16.72 M |
-$19.36 M |
-$17.68 M |
-$10.32 M |
| EBITDA Ratio |
-22.63
|
-6.51
|
-5.84
|
-0.69
|
-0.59
|
-0.64
|
-0.48
|
-1.07
|
-1.73
|
-1.56
|
| Operating Income Ratio |
-23.89
|
-13.68
|
-8.79
|
-0.37
|
-0.66
|
-0.64
|
-0.62
|
-1.18
|
-1.88
|
-1.28
|
| Total Other Income/Expenses Net |
$105,000.00
|
-$2.87 M
|
-$1.03 M
|
-$4.68 M
|
-$2.18 M
|
-$4.34 M
|
$921,000.00
|
$9,000.00
|
$215,982.00
|
-$4.57 M
|
| Income Before Tax |
-$15.81 M
|
-$18.58 M
|
-$8.65 M
|
-$7.40 M
|
-$20.37 M
|
-$22.96 M
|
-$15.80 M
|
-$21.37 M
|
-$18.99 M
|
-$13.04 M
|
| Income Before Tax Ratio |
-23.73
|
-16.18
|
-9.98
|
-1.01
|
-0.74
|
-0.79
|
-0.58
|
-1.18
|
-1.86
|
-1.97
|
| Income Tax Expense |
$6.88 M
|
$27.52 M
|
$546,000.00
|
-$512,000.00
|
-$59,000.00
|
-$2.08 M
|
$1.38 M
|
-$1.18 M
|
-$2.35 M
|
-$663,900.00
|
| Net Income |
-$22.69 M
|
-$46.10 M
|
-$9.20 M
|
-$6.71 M
|
-$20.37 M
|
-$20.88 M
|
-$15.80 M
|
-$20.18 M
|
-$16.64 M
|
-$12.37 M
|
| Net Income Ratio |
-34.07
|
-40.15
|
-10.61
|
-0.92
|
-0.74
|
-0.72
|
-0.58
|
-1.12
|
-1.63
|
-1.87
|
| EPS |
-3.87 |
-10.19 |
-18.5 |
-17.4 |
-111.98 |
-151.58 |
-149.45 |
-294 |
-264.2 |
-397.81 |
| EPS Diluted |
-3.87 |
-10.19 |
-18.5 |
-17.4 |
-111.98 |
-151.58 |
-149.45 |
-293.97 |
-263.85 |
-396.9 |
| Weighted Average Shares Out |
$5.87 M
|
$4.53 M
|
$497,200.00
|
$385,600.00
|
$181,938.00
|
$137,752.00
|
$105,739.00
|
$68,653.00
|
$62,994.00
|
$31,102.00
|
| Weighted Average Shares Out Diluted |
$5.87 M
|
$4.53 M
|
$497,200.00
|
$385,600.00
|
$181,938.00
|
$137,752.00
|
$105,739.00
|
$68,659.00
|
$63,077.00
|
$31,173.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
